Concepedia

Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy

Noelle K. LoConte, Maureen A. Smith, Dona Alberti, Jeffrey Bozeman, James F. Cleary, A Setala, Geoff Wodtke, George Wilding, Kyle D. Holen

Cancer Chemotherapy and Pharmacology · 2009 · 25 citations · 10 references

DOI

Concepts

References

10

How Many Imputations are Really Needed? Some Practical Clarifications of Multiple Imputation Theory

J. A. Graham, Allison E. Olchowski, Tamika D. Gilreath · Prevention Science · 2007 · 2.8K citations

, , +14

Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials

Laura F. Hutchins, Joseph M. Unger, John J. Crowley et al. · New England Journal of Medicine · 1999 · 2.2K citations

, , +13

Comorbidity and functional status are independent in older cancer patients.

Martine Extermann, Janine Overcash, Gary H. Lyman et al. · Journal of Clinical Oncology · 1998 · 989 citations

, , +17

Barriers to Clinical Trial Participation by Older Women With Breast Cancer

Margaret Kemeny, Bercedis L. Peterson, Alice B. Kornblith et al. · Journal of Clinical Oncology · 2003 · 467 citations

, , +11

Dealing with missing data

Judi Scheffer · Massey Research Online (Massey University) · 2002 · 332 citations · Full text

, , +8